Bepranemab
PSP002
Phase 1 small_molecule active
Quick answer
Bepranemab for Progressive Supranuclear Palsy is a Phase 1 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Progressive Supranuclear Palsy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active